Abstract:The coronavirus disease 2019 (COVID-19) pandemic caused extensive loss of life worldwide. Further, the COVID-19 and influenza mix-infection had caused great distress to the diagnosis of the disease. To control illness progression and limit viral spread within the population, a real-time reverse-transcription PCR (RT-PCR) assay for early diagnosis of COVID-19 was developed, but detection was time-consuming (4-6 h). To improve the diagnosis of COVID-19 and influenza, we herein developed a recombinase polymerase amplification (RPA) method for simple and rapid amplification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19 and Influenza A (H1N1, H3N2) and B (influenza B). Genes encoding the matrix protein (M) for H1N1, and the hemagglutinin (HA) for H3N2, and the polymerase A (PA) for Influenza B, and the nucleocapsid protein (N), the RNA-dependent-RNA polymerase (RdRP) in the open reading frame 1ab (ORF1ab) region, and the envelope protein (E) for SARS-CoV-2 were selected, and specific primers were designed. We validated our method using SARS-CoV-2, H1N1, H3N2 and influenza B plasmid standards and RNA samples extracted from COVID-19 and Influenza A/B (RT-PCR-verified) positive patients. The method could detect SARS-CoV-2 plasmid standard DNA quantitatively between 10(2) and 10(5) copies/ml with a log linearity of 0.99 in 22 min. And this method also be very effective in simultaneous detection of H1N1, H3N2 and influenza B. Clinical validation of 100 cases revealed a sensitivity of 100% for differentiating COVID-19 patients from healthy controls when the specificity was set at 90%. These results demonstrate that this nucleic acid testing method is advantageous compared with traditional PCR and other isothermal nucleic acid amplification methods in terms of time and portability. This method could potentially be used for detection of SARS-CoV-2, H1N1, H3N2 and influenza B, and adapted for point-of-care (POC) detection of a broad range of infectious pathogens in resource-limited settings.

Rapid detection of human adenovirus subgroup B using recombinase polymerase amplification assay

Rapid Detection of Human Adenovirus by Multiple Cross Displacement Amplification Combined with Nanoparticle-Based Biosensor Platform

A rapid and highly sensitive multiple detection of human adenovirus type 3, type 7 and respiratory syncytial virus by recombinase‐aided reverse transcription PCR

Rapid Detection of Influenza A Viruses Using a Real-Time Reverse Transcription Recombinase-Aided Amplification Assay.

Rapid Detection of Human Adenovirus by Loop-Mediated Isothermal Amplification of Nucleic Acids Extracted Using Magnetic Nanoparticle Enrichment Technology

Patterns of vitamin/mineral supplement usage by adolescents attending athletic high schools in Korea.

A multiplex recombinase polymerase amplification assay combined with CRISPR/Cas12a for the detection of respiratory syncytial virus and respiratory adenovirus

Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B

Development of a reverse transcription recombinase polymerase amplification assay for rapid detection of human respiratory syncytial virus

Molecular Typing and Rapid Identification of Human Adenoviruses Associated With Respiratory Diseases Using Universal PCR and Sequencing Primers for the Three Major Capsid Genes: Penton Base, Hexon, and Fiber

Use of a rapid reverse-transcription recombinase aided amplification assay for respiratory syncytial virus detection

Development of a loop-mediated isothermal amplification assay for the rapid detection of six common respiratory viruses

Rapid genotype recognition of human adenovirus based on surface-enhanced Raman scattering combined with machine learning

Epidemiological analysis of human adenovirus in children diagnosed with acute respiratory tract infection.

A simple test for penicillinase production in Staphylococcus aureus.

Utilization of Recombinase Polymerase Amplification Method Combined with Lateral Flow Dipstick for Visual Detection of Respiratory Syncytial Virus.

Establishment of RT-RPA-Cas12a assay for rapid and sensitive detection of human rhinovirus B

Prospective Evaluation of Rapid Antigen Tests for Diagnosis of Respiratory Viral Pathogens.

Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assay

Pharmacological stress testing and imaging: concluding remarks.

Direct Detection of Respiratory Syncytial Virus, Parainfluenza Virus, and Adenovirus in Clinical Respiratory Specimens by a Multiplex Reverse Transcription-PCR Assay